When entering a new market it is great to know the challenges and issues which those already taking part have at the top of their list. We posed this very question to over 200 individuals from a cross-section of the biosimilars industry and can provide you with an insight into this critical information.
And the results are in: the top strategic challenges and issues facing biosimilar and biobetter development pipelines are;
- Designing and undertaking proof of concept clinical trial
- Intellectual property challenges
- Regulatory challenges
- Successfully marketing a biosimilar
What are your top challenges when trying to take your drugs to market?
Interested in reading more on this topic? Take a look here:
For more updates on pharma, biotech and R&D, follow us on Twitter: @biopharmaevents or join our LinkedIn group: BioPharma- Networking for Pharmaceuticals, Biotech and R&D